A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors

Journal of Biological Chemistry

Volumn 293, Issue 9, 2018, Pages 3421-3435

  Faraz, Mahmood ^a   Herdenberg, Carl ^a   Holmlund, Camilla ^a   Henriksson, Roger ^a   Hedman, Håkan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ENCODING (SYMBOLS); ENZYMES; PLATELETS; SIGNAL ENCODING; TUMORS;

GROWTH FACTOR RECEPTORS; IMMUNOGLOBULIN-LIKE DOMAINS; LEUCINE-RICH REPEATS; MOLECULAR MECHANISM; NEGATIVE REGULATORS; PLATELET-DERIVED GROWTH FACTOR RECEPTORS; PROTEIN INTERACTION NETWORKS; RECEPTOR TYROSINE KINASE;

MOLECULAR BIOLOGY;

ARYLDIALKYLPHOSPHATASE 2; GLUTAREDOXIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GROWTH FACTOR RECEPTOR; HLA DR ANTIGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN CNPY3; PROTEIN CNPY4; PROTEIN GAL3ST1; PROTEIN GLRX3; PROTEIN GML; PROTEIN LRIG1; PROTEIN LRIG2; PROTEIN LRIG3; PROTEIN LRRC40; PROTEIN RAB4A; RAS PROTEIN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER AND BTB DOMAIN CONTAINING PROTEIN 16; LRIG1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ARTICLE; COMPUTER MODEL; DATA MINING; GENETIC CODE; GENETIC CORRELATION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; INTRACELLULAR SPACE; METABOLISM; PROTEIN TRANSPORT;

HUMANS; INTRACELLULAR SPACE; MEMBRANE GLYCOPROTEINS; PROTEIN INTERACTION MAPS; PROTEIN TRANSPORT; RECEPTORS, GROWTH FACTOR;

EID: 85042930541     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M117.807487     Document Type: Article

References (61)

1. Nilsson, J., Vallbo, C., Guo, D., Golovleva, I., Hallberg, B., Henriksson, R., and Hedman, H. (2001) Cloning, characterization, and expression of human LIG1. Biochem. Biophys. Res. Commun. 284, 1155-1161 CrossRef Medline
2. Holmlund, C., Nilsson, J., Guo, D., Starefeldt, A., Golovleva, I., Henriksson, R., and Hedman, H. (2004) Characterization and tissue-specific expression of human LRIG2. Gene 332, 35-43 CrossRef Medline
3. Guo, D., Holmlund, C., Henriksson, R., and Hedman, H. (2004) The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics 84, 157-165 CrossRef Medline
4. Nilsson, J., Starefeldt, A., Henriksson, R., and Hedman, H. (2003) LRIG1 protein in human cells and tissues. Cell Tissue Res. 312, 65-71 Medline
5. Suzuki, Y., Miura, H., Tanemura, A., Kobayashi, K., Kondoh, G., Sano, S., Ozawa, K., Inui, S., Nakata, A., Takagi, T., Tohyama, M., Yoshikawa, K., and Itami, S. (2002) Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia. FEBS Lett. 521, 67-71 CrossRef Medline
6. Jensen, K. B., Collins, C. A., Nascimento, E., Tan, D. W., Frye, M., Itami, S., and Watt, F. M. (2009) Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 4, 427-439 CrossRef Medline
7. Lu, L., Teixeira, V. H., Yuan, Z., Graham, T. A., Endesfelder, D., Kolluri, K., Al-Juffali, N., Hamilton, N., Nicholson, A. G., Falzon, M., Kschischo, M., Swanton, C., Wright, N. A., Carroll, B., Watt, F. M., et al. (2013) LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development. J. Pathol. 229, 608-620 CrossRef Medline
8. Powell, A. E., Wang, Y., Li, Y., Poulin, E. J., Means, A. L., Washington, M. K., Higginbotham, J. N., Juchheim, A., Prasad, N., Levy, S. E., Guo, Y., Shyr, Y., Aronow, B. J., Haigis, K. M., Franklin, J. L., and Coffey, R. J. (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149, 146-158 CrossRef Medline
9. Wong, V. W., Stange, D. E., Page, M. E., Buczacki, S., Wabik, A., Itami, S., van de Wetering, M., Poulsom, R., Wright, N. A., Trotter, M. W., Watt, F. M., Winton, D. J., Clevers, H., and Jensen, K. B. (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat. Cell Biol. 14, 401-408 CrossRef Medline
10. Hedman, H., Nilsson, J., Guo, D., and Henriksson, R. (2002) Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol. 41, 352-354 CrossRef Medline
11. Laederich, M. B., Funes-Duran, M., Yen, L., Ingalla, E., Wu, X., Carraway, K. L., 3rd, Sweeney, C. (2004) The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J. Biol. Chem. 279, 47050-47056 CrossRef Medline
12. Gur, G., Rubin, C., Katz, M., Amit, I., Citri, A., Nilsson, J., Amariglio, N., Henriksson, R., Rechavi, G., Hedman, H., Wides, R., and Yarden, Y. (2004) LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J. 23, 3270-3281 CrossRef Medline
13. Shattuck, D. L., Miller, J. K., Laederich, M., Funes, M., Petersen, H., Carraway, K. L., 3rd, Sweeney, C. (2007) LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol. Cell Biol. 27, 1934-1946 CrossRef Medline
14. Ledda, F., Bieraugel, O., Fard, S. S., Vilar, M., and Paratcha, G. (2008) Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF. J. Neurosci. 28, 39-49 CrossRef Medline
15. Rondahl, V., Holmlund, C., Karlsson, T., Wang, B., Faraz, M., Henriksson, R., and Hedman, H. (2013) Lrig2-deficient mice are protected against PDGFB-induced glioma. PLoS One 8, e73635 CrossRef Medline
16. Alsina, F. C., Hita, F. J., Fontanet, P. A., Irala, D., Hedman, H., Ledda, F., and Paratcha, G. (2016) Lrig1 is a cell-intrinsic modulator of hippocampal dendrite complexity and BDNF signaling. EMBO Rep. 17, 601-616 CrossRef Medline
17. Neirinckx, V., Hedman, H., and Niclou, S. P. (2017) Harnessing LRIG1- mediated inhibition of receptor tyrosine kinases for cancer therapy. Biochim. Biophys. Acta 1868, 109-116 Medline
18. van Erp, S., van den Heuvel, D. M., Fujita, Y., Robinson, R. A., Hellemons, A. J., Adolfs, Y., Van Battum, E. Y., Blokhuis, A. M., Kuijpers, M., Demmers, J. A., Hedman, H., Hoogenraad, C. C., Siebold, C., Yamashita, T., and Pasterkamp, R. J. (2015) Lrig2 negatively regulates ectodomain shedding of axon guidance receptors by ADAM proteases. Dev. Cell 35, 537-552 CrossRef Medline
19. Gumienny, T. L., Macneil, L., Zimmerman, C. M., Wang, H., Chin, L., Wrana, J. L., and Padgett, R. W. (2010) Caenorhabditis elegans SMA-10/ LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling. PLoS Genet. 6, e1000963 CrossRef Medline
20. Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., Dong, R., Guarani, V., Vaites, L. P., Ordureau, A., Rad, R., et al. (2015) The BioPlex network: a systematic exploration of the human interactome. Cell 162, 425-440 CrossRef Medline
21. Huttlin, E. L., Bruckner, R. J., Paulo, J. A., Cannon, J. R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M. P., Parzen, H., Szpyt, J., Tam, S., Zarraga, G., Pontano-Vaites, L., Swarup, S., et al. (2017) Architecture of the human interactome defines protein communities and disease networks. Nature 545, 505-509 CrossRef Medline
22. Eriksson, A., Siegbahn, A., Westermark, B., Heldin, C. H., and Claesson- Welsh, L. (1992) PDGFβ- andβ-receptors activate unique and common signal transduction pathways. EMBO J. 11, 543-550 Medline
23. Sjödin, A., Guo, D., Hofer, P. A., Henriksson, R., and Hedman, H. (2003) Mammaglobin in normal human sweat glands and human sweat gland tumors. J. Invest. Dermatol. 121, 428-429 CrossRef Medline
24. Krig, S. R., Frietze, S., Simion, C., Miller, J. K., Fry, W. H., Rafidi, H., Kotelawala, L., Qi, L., Griffith, O. L., Gray, J. W., Carraway, K. L., 3rd, Sweeney, C. (2011) Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ER-positive breast cancer. Mol. Cancer Res. 9, 1406-1417 CrossRef Medline
25. Liu, T. M., Lee, E. H., Lim, B., and Shyh-Chang, N. (2016) Concise review: balancing stem cell self-renewal and differentiation with PLZF. Stem Cells 34, 277-287 CrossRef Medline
26. Rao, D. D., Vorhies, J. S., Senzer, N., and Nemunaitis, J. (2009) siRNA vs. shRNA: similarities and differences. Adv. Drug Deliv. Rev. 61, 746-759 CrossRef Medline
27. Zhang, T., Dong, K., Liang, W., Xu, D., Xia, H., Geng, J., Najafov, A., Liu, M., Li, Y., Han, X., Xiao, J., Jin, Z., Peng, T., Gao, Y., Cai, Y., et al. (2015) G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L. Elife 4, e06734 Medline
28. Kinnersley, B., Labussière, M., Holroyd, A., Di Stefano, A. L., Broderick, P., Vijayakrishnan, J., Mokhtari, K., Delattre, J. Y., Gousias, K., Schramm, J., Schoemaker, M. J., Fleming, S. J., Herms, S., Heilmann, S., Schreiber, S., et al. (2015) Genome-wide association study identifies multiple susceptibility loci for glioma. Nat. Commun. 6, 8559 CrossRef Medline
29. Melin, B. S., Barnholtz-Sloan, J. S., Wrensch, M. R., Johansen, C., Il'yasova, D., Kinnersley, B., Ostrom, Q. T., Labreche, K., Chen, Y., Armstrong, G., Liu, Y., Eckel-Passow, J. E., Decker, P. A., Labussière, M., Idbaih, A., et al. (2017) Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat. Genet. 49, 789-794 CrossRef Medline
30. Rafidi, H., Mercado, F., 3rd, Astudillo, M., Fry, W. H., Saldana, M., Carraway, K. L., 3rd, Sweeney, C. (2013) Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3). J. Biol. Chem. 288, 21593-21605 CrossRef Medline
31. Meabon, J. S., de Laat, R., Ieguchi, K., Serbzhinsky, D., Hudson, M. P., Huber, B. R., Wiley, J. C., and Bothwell, M. (2016) Intracellular LINGO-1 negatively regulates Trk neurotrophin receptor signaling. Mol. Cell Neurosci. 70, 1-10 CrossRef Medline
32. Hagmann, H., Kuczkowski, A., Ruehl, M., Lamkemeyer, T., Brodesser, S., Horke, S., Dryer, S., Schermer, B., Benzing, T., and Brinkkoetter, P. T. (2014) Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane. FASEB J. 28, 1769-1779 CrossRef Medline
33. Teiber, J. F., Horke, S., Haines, D. C., Chowdhary, P. K., Xiao, J., Kramer, G. L., Haley, R. W., and Draganov, D. I. (2008) Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone. Infect. Immun. 76, 2512-2519 CrossRef Medline
34. Devarajan, A., Bourquard, N., Hama, S., Navab, M., Grijalva, V. R., Morvardi, S., Clarke, C. F., Vergnes, L., Reue, K., Teiber, J. F., and Reddy, S. T. (2011) Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid. Redox Signal. 14, 341-351 CrossRef Medline
35. Horke, S., Witte, I., Wilgenbus, P., Krüger, M., Strand, D., and Förstermann, U. (2007) Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 115, 2055-2064 CrossRef Medline
36. Nagarajan, A., Dogra, S. K., Sun, L., Gandotra, N., Ho, T., Cai, G., Cline, G., Kumar, P., Cowles, R. A., and Wajapeyee, N. (2017) Paraoxonase 2 facilitates pancreatic cancer growth and metastasis by stimulating GLUT1- mediated glucose transport. Mol. Cell 67, 685-701.e6 CrossRef Medline
37. Xu, Y., Tan, L. J., Grachtchouk, V., Voorhees, J. J., and Fisher, G. J. (2005) Receptor-type protein-tyrosine phosphatase-β regulates epidermal growth factor receptor function. J. Biol. Chem. 280, 42694-42700 CrossRef Medline
38. Tarcic, G., Boguslavsky, S. K., Wakim, J., Kiuchi, T., Liu, A., Reinitz, F., Nathanson, D., Takahashi, T., Mischel, P. S., Ng, T., and Yarden, Y. (2009) An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis. Curr. Biol. 19, 1788-1798 CrossRef Medline
39. Honke, K., Tsuda, M., Hirahara, Y., Ishii, A., Makita, A., and Wada, Y. (1997) Molecular cloning and expression of cDNA encoding human 3′- phosphoadenylylsulfate:galactosylceramide 3′-sulfotransferase. J. Biol. Chem. 272, 4864-4868 CrossRef Medline
40. Hirate, Y., and Okamoto, H. (2006) Canopy1, a novel regulator of FGF signaling around the midbrain-hindbrain boundary in zebrafish. Curr. Biol. 16, 421-427 CrossRef Medline
41. Matsui, T., Thitamadee, S., Murata, T., Kakinuma, H., Nabetani, T., Hirabayashi, Y., Hirate, Y., Okamoto, H., and Bessho, Y. (2011) Canopy1, a positive feedback regulator of FGF signaling, controls progenitor cell clustering during Kupffer's vesicle organogenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 9881-9886 CrossRef Medline
42. Liu, B., Yang, Y., Qiu, Z., Staron, M., Hong, F., Li, Y., Wu, S., Li, Y., Hao, B., Bona, R., Han, D., and Li, Z. (2010) Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nat. Commun. 1, 79 Medline
43. Wandinger-Ness, A., and Zerial, M. (2014) Rab proteins and the compartmentalization of the endosomal system. Cold Spring Harb. Perspect. Biol. 6, a022616 CrossRef Medline
44. Frittoli, E., Palamidessi, A., Marighetti, P., Confalonieri, S., Bianchi, F., Malinverno, C., Mazzarol, G., Viale, G., Martin-Padura, I., Garré, M., Parazzoli, D., Mattei, V., Cortellino, S., Bertalot, G., Di Fiore, P. P., and Scita, G. (2014) A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination. J. Cell Biol. 206, 307-328 CrossRef Medline
45. Tanemura, A., Nagasawa, T., Inui, S., and Itami, S. (2005) LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases. Dermatol. Surg. 31, 423-430 CrossRef Medline
46. Thompson, P. A., Ljuslinder, I., Tsavachidis, S., Brewster, A., Sahin, A., Hedman, H., Henriksson, R., Bondy, M. L., and Melin, B. S. (2014) Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer. Cancer Res. 74, 2928-2935 CrossRef Medline
47. Kvarnbrink, S., Karlsson, T., Edlund, K., Botling, J., Lindquist, D., Jirström, K., Micke, P., Henriksson, R., Johansson, M., and Hedman, H. (2015) LRIG1 is a prognostic biomarker in non-small cell lung cancer. Acta Oncol. 54, 1113-1119 CrossRef Medline
48. Yokdang, N., Hatakeyama, J., Wald, J. H., Simion, C., Tellez, J. D., Chang, D. Z., Swamynathan, M. M., Chen, M., Murphy, W. J., Carraway Iii, K. L., and Sweeney, C. (2016) LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene 35, 2932-2947 CrossRef Medline
49. Wang, J., Huo, K., Ma, L., Tang, L., Li, D., Huang, X., Yuan, Y., Li, C., Wang, W., Guan, W., Chen, H., Jin, C., Wei, J., Zhang, W., Yang, Y., et al. (2011) Toward an understanding of the protein interaction network of the human liver. Mol. Syst. Biol. 7, 536 Medline
50. Kristensen, A. R., Gsponer, J., and Foster, L. J. (2012) A high-throughput approach for measuring temporal changes in the interactome. Nat. Methods 9, 907-909 CrossRef Medline
51. Wan, C., Borgeson, B., Phanse, S., Tu, F., Drew, K., Clark, G., Xiong, X., Kagan, O., Kwan, J., Bezginov, A., Chessman, K., Pal, S., Cromar, G., Papoulas, O., Ni, Z., et al. (2015) Panorama of ancient metazoan macromolecular complexes. Nature 525, 339-344 CrossRef Medline
52. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I. M., Gallia, G. L., Olivi, A., McLendon, R., Rasheed, B. A., Keir, S., Nikolskaya, T., et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 CrossRef Medline
53. Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., Friedman, H., Friedman, A., Reardon, D., Herndon, J., Kinzler, K. W., et al. (2009) IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765-773 CrossRef Medline
54. Yi, W., Holmlund, C., Nilsson, J., Inui, S., Lei, T., Itami, S., Henriksson, R., and Hedman, H. (2011) Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. Exp. Cell Res. 317, 504-512 CrossRef Medline
55. Johansson, M., Oudin, A., Tiemann, K., Bernard, A., Golebiewska, A., Keunen, O., Fack, F., Stieber, D., Wang, B., Hedman, H., and Niclou, S. P. (2013) The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status. Neuro Oncol. 15, 1200-1211 CrossRef Medline
56. Gietz, R. D., and Woods, R. A. (2001) Genetic transformation of yeast. BioTechniques 30, 816-820, 822-826, 828 passim Medline
57. Serebriiskii, I. G., and Golemis, E. A. (2000) Uses of lacZ to study gene function: evaluation of-galactosidase assays employed in the yeast twohybrid system. Anal. Biochem. 285, 1-15 CrossRef Medline
58. Kolonin, M. G., Zhong, J., and Finley, R. L. (2000) Interaction mating methods in two-hybrid systems. Methods Enzymol. 328, 26-46 CrossRef Medline
59. Robinson, M. D., McCarthy, D. J., and Smyth, G. K. (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 CrossRef Medline
60. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 CrossRef Medline
61. Bolte, S., and Cordelières, F. P. (2006) A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213-232 CrossRef Medline